News

March 19, 2018March 19, 2018

Leukemia Therapy Shows Potent Activity Against Rare Ovarian Cancer, Study Finds

News

Ponatinib, an approved leukemia therapy sold under the brand name Iclusig, may be effective against tumors in a rare and aggressive form of ovarian cancer, research suggests. Led by researchers ... Read more

March 16, 2018March 16, 2018

Metformin, Statins Do Not Reduce Incidence of Ovarian Cancer in Women with Type 2 Diabetes, Study Says

News

Women with type 2 diabetes taking metformin or statins are not less likely to develop epithelial ovarian cancer than any other type 2 diabetes patient, a large Finnish cohort study ... Read more

March 14, 2018March 14, 2018

BARD1 Test Detected Ovarian Cancer in 82% of Patients with the Disease, Study Shows

News

A new BARD1 Life Sciences test was able to detect ovarian cancer in 82% of those with the disease, the company announced. The 400 cases in the BARD1-Ovarian test study covered all stages and ... Read more

March 12, 2018March 12, 2018

Gene Mutations Increasing Ovarian Cancer Risk May Be Passed Down from Fathers, Study Suggests

News

Mutations in a newly identified gene that may increase women’s risk of ovarian cancer could be passed down through the X chromosome, a new study shows. The findings suggest that ... Read more

March 9, 2018March 9, 2018

New Global Study Puts Focus on Patients with Rare ROS1-Positive Cancer

News

A new global study has been launched to help gain a deeper understanding of ROS1 gene fusions, a rare cause of some types of cancers, including ovarian. The initiative is ... Read more

March 7, 2018March 7, 2018

Protein’s Expression on Immune Cells May Predict Response to Immunotherapy, Study Shows

News

Expression of a certain protein on two types of immune cells could help predict which cancer patients will respond to a specific immunotherapy, a study shows. The study, “Host expression of ... Read more

March 5, 2018

FDA Grants Orphan Drug Status to GamaMabs’ GM102 for Treatment of Gynecological Cancers

News

The U.S. Food and Drug Administration granted orphan drug status to GamaMabs Pharma’s investigative therapy GM102 for the treatment of gynecological cancers, including ovarian, fallopian tube, and primary peritoneal cancers. The ... Read more

March 2, 2018March 2, 2018

Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes

News

Researchers have discovered new gene variants that affect how ovarian cancer patients respond to standard chemotherapy treatments Paraplatin (carboplatin) and Taxol (paclitaxel). The variants influence how a patient processes chemotherapy medications. ... Read more

February 28, 2018February 28, 2018

Potential Therapeutic Target Identified to Fight Metastasis in Ovarian Cancer

News

High levels of CXCR4, a receptor for signaling molecules that drive cell movement, allow ovarian cancer cells to grow faster and spread to other parts of the body, a study ... Read more

February 26, 2018February 26, 2018

EMA’s CHMP Recommends Lynparza as Maintenance Therapy for Platinum-sensitive Ovarian Cancer

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that Lynparza (olaparib) be approved to prevent disease progression and relapse in ovarian cancer patients who responded to platinum-based ... Read more